Framework Journal · one stock, one dated entry

Recorded 2026-07-19 · Permanent

Tesla, Inc. logoTesla, Inc. TSLA

Titan Ethical

An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.

In plain words · Tesla, Inc.

The label
Accumulation

read at $380.84

Tesla, Inc. holds its Accumulation at $380.84.

PHINPOOPSC
  • PHPhase · the trend structure carries the Accumulation label
  • INInsiders · no filings inside 60 days, left as found
  • POPositioning · no disclosures inside 60 days, left as found
  • OPOptions · no verdict drawn today, left as found
  • SCScreen · passes the values gate
  • edge confirmed
  • edge broken
  • edge forming

Each arm is one independent read. Conviction is not a single call, it is how many edges converge.

The investor read · the season, not the day

As held on the ledger · 2026-07-19
PhaseAccumulation
Quantitative stateConsolidating, no directional conviction, held for 223 days
Price$380.84
Valuation346.22 trailing · 149.11 forward price to earnings
Values screenPASS · score 80.1
Beta1.80

The values screen, explained · five checks, plain English

Full pass across all five screens. This security clears the Titan Ethical Standard — its business and its balance sheet both stay inside the lines.

  • Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
  • Debt load Interest-bearing debt is just 10.7% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
  • Interest-bearing cash Cash held in interest-bearing accounts and securities is 20.0% of assets, under the one-third limit. Pass
  • Receivables Money owed to the company is 15.3% of assets, under the 49% limit. Pass
  • Revenue purity Only 1.8% of revenue comes from non-compliant sources — under the 5% line. Pass

Five checks adapted from AAOIFI screening standards — business activity plus four balance-sheet ratios. All five must pass for ethical clearance.

The opportunity · what the numbers say it is worth

Our framework reads AVOID — it trades above our $240.79 fair value estimate, weak competitive moat, 15.80% revenue growth.

Read at
$380.84
346.22 P/E · 149.11 fwd
Our fair value
$240.79
37% premium
Analyst target (avg)
$460.00
+21% to current
Target low $125.00Analyst target rangeTarget high $600.00
▲ current $380.84 · | average target

Price history & projections · where it has been, where the models see it going

$634$387$140TODAY5y agoPROJECTIONAnalyst high$600.00 +57%Analyst avg$460.00 +21%Our fair value$240.79 -37%Conservative$190.42 -50%

The valuation journey · where the price sits against fair value and the Street

Current
$380.84
you are here
Conservative
$190.42
-50%
Analyst avg
$460.00
+21%
Our fair value
$240.79
-37%
Analyst high
$600.00
+58%

Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.

Revenue growth15.80%
Profit margin3.95%
Debt to equity18.74
Analyst consensusBuy · 39 covering

Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.

The business, in plain words · what the numbers mean

Electric cars priced far beyond their profits

Walk past any Tesla showroom and the excitement feels real, with buyers chasing the next battery upgrade or self driving promise. That appeal fades fast once you check the numbers, because shares trade at 149 times forward earnings against our fair value that sits 37 percent lower.

We pass for straightforward reasons. Revenue growth has cooled to 16 percent, profit margins sit at only 4 percent and return on equity is stuck at 5 percent, all inside a business with a weak moat. The auto sector is cyclical, so stretched multiples like this often signal peak expectations rather than a bargain.

Demand swings can hit hard when rivals flood the market with cheaper models, and thin returns leave little cushion if volumes slow. The buy consensus from analysts does not change the gap between price and value.

Analysis, not advice.

The fundamentals · plain-English read
Forward P/E149.1x
expensive even after accounting for its growth
Trailing P/E346.2x
expensive — the price assumes strong growth ahead
Revenue growth15.8%
steady growth
Profit margin3.9%
barely profitable
Return on equity4.9%
a modest return on shareholder capital
Debt to equity0.19
minimal debt — a conservative balance sheet
Current ratio2.04
comfortably covers its short-term bills
Beta1.80
much more volatile than the market
Market cap$1.43T
Employees134,785

The risks · The things to watch: it already moves more than the market on an average day.

Plain-English interpretation of our own screen data. Analysis, not advice.

Latest news · what the market is reading on TSLA

Headlines from third-party outlets, linked for reference — not our reporting, not advice.

Related securities · others in TSLA's space worth a look

Screened names in the same industry · explore each on its own page.

Where & how to trade · wherever in the world you are

TSLA trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The trader read · the latest dated commentary

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (41 analysts) rates it buy, with a mean price target of $412. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis. Entered 2026-07-19 · Accumulation

The dated journal · newest first, never edited

2026-07-19 Accumulation $380.84 -2.6% Entry 6

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (41 analysts) rates it buy, with a mean price target of $412. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-18 Accumulation $391.00 +0.0% Entry 5

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (41 analysts) rates it buy, with a mean price target of $412. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-17 Accumulation $391.00 +0.0% Entry 4

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (41 analysts) rates it buy, with a mean price target of $412. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-16 Accumulation $391.00 +0.0% Entry 3

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (41 analysts) rates it buy, with a mean price target of $412. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-03 Accumulation $391.00 +0.0% Entry 2

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns.

2026-07-02 Accumulation $391.00 Entry 1

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The insider ledger · Form 4 filings, as filed

Most recent filings · TSLA
DateInsiderTitleTypeSharesValue
2026-05-13 Taneja Vaibhav CFO Sale 3,000 $1,350,000
2026-04-30 Wilson-Thompson Kathleen Dir Sale 26,409 $9,985,390
2026-03-30 Wilson-Thompson Kathleen Dir Sale 25,809 $9,273,888
2026-03-06 Taneja Vaibhav CFO Sale 2,265 $899,077
2026-02-25 Wilson-Thompson Kathleen Dir Sale 25,731 $10,692,814
2026-01-02 Murdoch James R Dir Sale 60,000 $26,723,781
2025-12-09 Musk Kimbal Dir Sale 56,820 $25,606,501
2025-12-08 Taneja Vaibhav CFO Sale 2,637 $1,170,635
2025-09-15 Murdoch James R Dir Sale 60,000 $25,360,800
2025-09-12 Musk Elon CEO, 10% Purchase 2,568,732 $999,959,042

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The political ledger · congressional disclosures

Disclosures naming TSLA
DatePoliticianPartyTypeAmount
27 May2026 Ro Khanna Democrat buy 1K–15K
2026-04-13 Ro Khanna Democrat Sale 1K–15K
2025-03-15 Suzan DelBene buy 30000
2024-11-15 Gil Cisneros buy 20000
2024-01-10 Marjorie Taylor Greene buy 20000

What holding actually paid · price plus dividends

If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $445.00 -14.3% · $858 -14.3%
2 months $348.95 +9.4% · $1,094 +9.4%
3 months $395.01 -3.4% · $966 -3.4%
6 months $446.89 -14.6% · $854 -14.6%
1 year $326.09 +17.0% · $1,170 +17.0%
2 years $173.79 +119.6% · $2,196 +119.6%
3 years $244.40 +56.1% · $1,561 +56.1%
5 years $203.30 +87.7% · $1,877 +87.7%

Historical returns from market close data. Past performance does not guarantee future results.

This entry now belongs to the ledger. Whatever TSLA does next, these words stay.

Tesla, Inc. · TSLA · Accumulation · $380.84
Recorded 2026-07-19 · before the outcome · scored mechanically

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry Indicators Options Calendar Composites Boycott Tracker Convergence Screener Fed Tracker Explore All Is It Halal? Earnings Calendar Dividend Screener Country Guides Glossary Join Free →

Get our weekly market brief free.